Literature DB >> 6995484

Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.

C L Anderson, W S Stillman.   

Abstract

We asked whether binding of human immunoglobulin (Ig)G antibody reacting with Raji cells could be distinguished from binding of IgG immune complexes. Using a standard Raji assay employing 125I-IgG goat anti-human Fc gamma, we found that digestion of Raji cells with pronase reduced by 95% their ability to bind complement-fixed aggregated human gamma globulin and complement-fixed tetanus toxoid-antitetanus toxin complexes. However, binding at 37 degrees C of IgG from the sera of 16 patients with systemic lupus erythematosus (SLE) to pronase-digested Raji cells was reduced much less consistently and extensively (9-100% reduction; mean reduction of 51%). In more detailed studies of two SLE sera, sucrose density gradient centrifugation showed that greater than 50% of the IgG binding to undigested Raji cells sedimented in the 7S region. Pepsin digestion of immunoglobulin fractions from four SLE sera caused a reduction in SLE IgG binding to undigested Raji cells when detected with 125I anti-Fc gamma, but an increase when binding was detected with 125I-anti-Fab, suggesting that substantial SLE IgG can bind through F(ab')2 regions. Binding of IgG from SLE sera was not directed at neoantigenic sites induced by pronase digestion because binding activity was adsorbed with undigested cells as readily as with digested cells. Moreover, sera from 10 SLE patients that had negative Raji assays contained no IgG that bound to pronase-digested Raji cells. We conclude that much of the IgG bound at 37 degrees C to Raji cells from the sera of many patients with SLE does not represent immune complexes but is probably antibody directed toward sites on the Raji cell.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995484      PMCID: PMC371717          DOI: 10.1172/JCI109863

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.

Authors:  J L Feldmann; M J Becker; H Moutsopoulos; K Fye; M Blackman; W V Epstein; N Talal
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

2.  Cytotoxins in disease. Autocytotoxins in lupus.

Authors:  P I Terasaki; V D Mottironi; E V Barnett
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

3.  General methods for the study of cells and serum during the immune response: the response to dinitrophenyl in mice.

Authors:  N R Klinman; R B Taylor
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

6.  Serum and synovial fluid inhibitors of antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.

Authors: 
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

7.  Studies of human sera with cytotoxic activity.

Authors:  R C Williams; J D Emmons; E J Yunis
Journal:  J Clin Invest       Date:  1971-07       Impact factor: 14.808

8.  Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; P Wernet; S M Fu; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

9.  Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions.

Authors:  P Wernet; H G Kunkel
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  14 in total

1.  Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.

Authors:  S S Levinson; J O Goldman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

2.  Fluorescent anti-immunoglobulin G assay of circulating immune complexes extracted with polyethylene glycol.

Authors:  S S Levinson; J Goldman
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

Review 3.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

Review 4.  Pitfalls in the methodology for detection of immune complexes.

Authors:  R Heimer; S Per
Journal:  Surv Immunol Res       Date:  1982

5.  Cross-reacting rheumatoid factors and lupus erythematosus (LE)-factors.

Authors:  K Hannestad; O P Rekvig; A Husebekk
Journal:  Springer Semin Immunopathol       Date:  1981

6.  Reactivity of low molecular weight material in cellular immune complex assays.

Authors:  K M Cooper; M Moore
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

7.  Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays.

Authors:  R P Taylor; B S Andrews; K W Morley; T Conlon
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

8.  The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice.

Authors:  N J Alexander; N L Smythe; M P Jokinen
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

9.  Lymphocytotoxic antibodies in primary biliary cirrhosis.

Authors:  A Parés; J Martorell; J Caballería; J Vives; M Bruguera; J Rodés
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

10.  Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.

Authors:  M T Aguado; J D Lambris; G C Tsokos; R Burger; D Bitter-Suermann; J D Tamerius; F J Dixon; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.